The association between LOC122787137 (CDK7 Strongly-Dependent Group 2 Enhancer GRCh37_chr2:71829831-71831030) and Dysferlinopathy is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants26
Symptoms0
Compounds0
Trials0
Publications2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.